Time is running out to change a trade deal that could jeopardize people's access to affordable medicines
WHAT CAN YOU DO?
Learn more about the Trans-Pacific Partnership
Many countries and treatment providers, including Doctors Without Borders/Médecins Sans Frontières (MSF), rely on affordable quality generic medicines to treat life-threatening diseases. We need to keep prices low so our patients—and millions of others still waiting for treatment in the developing world—can get the medicines they need.
But right now the U.S. government is advocating for a trade deal with eleven other Pacific Rim nations that includes terms that will restrict access to generic medicines, making life-saving treatments unaffordable to millions.
Damaging intellectual property rules in the U.S.-led Trans-Pacific Partnership Agreement (TPP) would give pharmaceutical companies longer monopolies over brand name drugs. Companies would be able to charge high prices for longer periods of time. And it would be much harder for generic companies to produce cheaper drugs that are vital to people’s health.
If harmful provisions in the U.S. proposals for the TPP agreement are not removed before it is too late, this trade deal will have a real cost in human lives.
Tell US Congress to protect access to medicines
Don't let the #TPP trade away access to medicines for millions. #BadDealforMedicine Tweet #Baddealformedicine
#TPP countries must say 'no' to harmful rules that keep drug prices high #BadDealforMedicine Tweet #Baddealformedicine
Write to President Obama
MSF has written to President Obama about the TPP in 2013, 2014, and together as part of a coalition. He should hear from you too. Tell President Obama to protect access to medicines for poor people. Check out our suggested script and submit your comments to the White House here.
Dear President Obama:
I am writing to urge you and the U.S. government to withdraw aggressive provisions in the Trans-Pacific Partnership that will restrict access to affordable medicines for millions of people. I am concerned about specific provisions in the intellectual property, investment and pharmaceutical pricing chapters that will make it harder for patients, governments and treatment providers to access affordable generic medicines in developing countries. Too many people already suffer and die because the medicines they need are too expensive or do not exist. I cannot stand by as this proposed agreement threatens to restrict access even further. Through its global health programs, the U.S. has helped millions of people living in developing countries, and continues to invest heavily to end and control some of the world’s most devastating diseases. I urge you to ensure that the TPP does not sabotage these efforts and existing programs. Medicines should not be a luxury.
Post this message on your Facebook page:
HELP MSF FIX THE TPP. If enacted in its current form, the TPP trade deal will lower the standards for patenting of medicines. Companies would be granted patents for modifications to existing drugs. It would also delay the availability of affordable versions of biologics, a new class of drugs that includes everything from cancer medicines to vaccines: www.doctorswithoutborders.org/tpp
Join the movement
ARTICLES RELATED TO TPP